BRIEF published on 10/21/2025 at 18:35, 3 months 13 days ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/21/2025 at 18:35, 3 months 13 days ago Theraclion obtient une certification cruciale en Chine Medical Theraclion SONOVEIN® Ultrasons Focalisés Certification Chinoise
PRESS RELEASE published on 10/21/2025 at 18:30, 3 months 13 days ago Informations privilégiées / Autres communiqués Theraclion obtient une certification chinoise majeure pour son dispositif Sonovein® et progresse vers l'accès au marché en Chine, renforçant ainsi sa position dans le secteur des technologies médicales avancées Marché Chinois Technologies Médicales Theraclion SONOVEIN® Certification Chinoise
BRIEF published on 10/10/2025 at 18:35, 3 months 24 days ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
BRIEF published on 10/10/2025 at 18:35, 3 months 24 days ago Publication mensuelle des droits de vote de Theraclion Investissement Droits De Vote Capital Social Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 3 months 24 days ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
PRESS RELEASE published on 10/10/2025 at 18:30, 3 months 24 days ago Informations privilégiées / Autres communiqués Communiqué mensuel sur les droits de vote et actions de Theraclion, société française de MedTech. Détails des actions en circulation et droits de vote réels Euronext PEA PME MedTech France Theraclion
BRIEF published on 09/15/2025 at 18:35, 4 months 18 days ago Theraclion Réussit son Étude Pivotal avec un Taux d'Occlusion de 96,8 % FDA Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 09/15/2025 at 18:35, 4 months 18 days ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
PRESS RELEASE published on 09/15/2025 at 18:30, 4 months 18 days ago Informations privilégiées / Autres communiqués Theraclion annonce le succès de son étude pivotale américaine FDA avec un taux d'occlusion de 96,8% pour Sonovein®, sa plateforme de traitement des varices par ultrasons focalisés de haute intensité FDA Theraclion SONOVEIN Étude Pivotale Occlusion
Published on 02/04/2026 at 02:15, 3 hours 11 minutes ago Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 5 hours 26 minutes ago Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 5 hours 56 minutes ago FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 6 hours 14 minutes ago Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 6 hours 56 minutes ago Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million
Published on 02/04/2026 at 02:05, 3 hours 20 minutes ago Saudi Arabia Preparing for AlUla Emerging Market Economies Conference to be Held February 8-9, 2026
Published on 02/04/2026 at 00:42, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3X - Initial Director's Interest Notice
Published on 02/03/2026 at 20:57, 8 hours 29 minutes ago EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 8 hours 49 minutes ago Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 9 hours 20 minutes ago KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026
Published on 02/03/2026 at 18:00, 11 hours 26 minutes ago Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 11 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 11 hours 41 minutes ago Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)
